Ignite High Endurance Pre-Workout Supplement with Caffeine, brand Back to Health, Net wt. 1 lb. UPC 8 01650 01540 2. Ignite High Endu...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (fire or burn). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1174-2018.
Ignite High Endurance Pre-Workout Supplement with Caffeine dietary supplement product is recalled because label declared WHEY protein but do not declare milk.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1174-2018.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Independent Nutrition, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1174-2018.
Independent Nutrition, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Independent Nutrition, Inc. Recall FAQ
Independent Nutrition, Inc. is the subject of a supplements safety report: Ignite High Endurance Pre-Workout Supplement with Caffeine, brand Back to Health, Net wt. 1 lb. UPC 8 01650 01540 2. Ignite High Endu.... The notice was published on March 28, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.